MRC announcement of Pathology Nodes at East Midlands Breathomics Pathology Node (EMBER) and Nottingham Molecular Pathology Node (NMPN)

27 July 2015. Source: Medical Research Council

 

MRC announcement of Pathology Nodes at East Midlands Breathomics Pathology Node (EMBER) - Institutions University of Leicester, Loughborough University and University Hospitals of Leicester NHS Trust - £2.5m The air we breathe out contains a cocktail of volatile organic compounds that give a snapshot of the biological processes taking place in the lung and beyond. The Leicester node will help develop breath analysis tests that use the same technology as that used to detect explosives in war zones.  It’s hoped these could give an instant diagnosis and help doctors pick the best treatments for a range of conditions, including cancers, respiratory infections and diseases such as asthma and chronic obstructive pulmonary disease. See also: Nottingham press release

MRC announcement of Pathology Nodes at: Nottingham Molecular Pathology Node (NMPN) for Integrated Multi-platform Biomarker Research and Knowledge Transfer - £2.4m. The Nottingham node will bring together informatics, computational modelling and molecular pathology to find new biomarkers for a range of diseases – particularly those affecting the digestive and respiratory systems and the liver. These new markers will help doctors pick the best treatments for their patients.